ANALYSIS: White labelling is a global phenomenon, but are there winners and losers?
Commerce Commission a wild card in play for sport rights.
Investors are not always behind companies’ PC philosophy and practice.
Shoeshine: Investors should look deeper than celebrity pull.
Shoeshine: Uncompromising directors who act like owners impel their companies to make money.
Shoeshine: Mystery surrounds why Michael Talley is no longer involved in the company.
The cancer diagnostics company has been undercapitalised from the get-go.
The reality of the wine industry is not as glossy as its marketing suggests, some growers say.
42 Below and Ecoya made money for investors eventually but their creators are struggling with beer marketer Moa.
Shoeshine: Shareholders have little choice but to hope a huge rights issue will rescue their company.